1. Home
  2. BRID vs IBIO Comparison

BRID vs IBIO Comparison

Compare BRID & IBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bridgford Foods Corporation

BRID

Bridgford Foods Corporation

N/A

Current Price

$7.90

Market Cap

72.0M

ML Signal

N/A

Logo iBio Inc.

IBIO

iBio Inc.

HOLD

Current Price

$1.86

Market Cap

72.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BRID
IBIO
Founded
1932
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Specialty Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
72.0M
72.2M
IPO Year
1995
2009

Fundamental Metrics

Financial Performance
Metric
BRID
IBIO
Price
$7.90
$1.86
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$4.75
AVG Volume (30 Days)
1.7K
925.9K
Earning Date
06-01-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
73.08
EPS
N/A
N/A
Revenue
$174,257,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
4.21
N/A
52 Week Low
$7.00
$0.56
52 Week High
$8.73
$3.82

Technical Indicators

Market Signals
Indicator
BRID
IBIO
Relative Strength Index (RSI) 54.00 54.58
Support Level $7.31 $1.70
Resistance Level $8.07 $2.29
Average True Range (ATR) 0.20 0.14
MACD 0.01 0.05
Stochastic Oscillator 64.74 74.18

Price Performance

Historical Comparison
BRID
IBIO

About BRID Bridgford Foods Corporation

Bridgford Foods Corp manufactures, markets, and distributes frozen and snack food products in the United States. The two business segments are: the processing and distribution of frozen products, and the processing and distribution of snack food products. Its product offerings include meat snacks, breads and rolls, biscuits, and ready-to-eat sandwiches, among others. The company offers frozen food products to the foodservice and retail customers through wholesalers, cooperatives, and distributors; and snack food items to supermarkets, mass merchandise, and convenience retail stores through customer-owned distribution centers, as well as a direct store delivery network. A majority of the company's revenue is derived from the snack food products segment.

About IBIO iBio Inc.

iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.

Share on Social Networks: